|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Leung CS, Yeung TL, Yip KP, Wong KK, Ho
SY, Mangala LS, Sood AK, Lopez-Berestein G, Sheng J, Wong ST, et
al: Cancer-associated fibroblasts regulate endothelial adhesion
protein LPP to promote ovarian cancer chemoresistance. J Clin
Invest. 128:589–606. 2018. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2016. CA Cancer J Clin. 66:7–30. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dasari S and Tchounwou PB: Cisplatin in
cancer therapy: Molecular mechanisms of action. Eur J Pharmacol.
740:364–378. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Batista ML Jr, Olivan M, Alcantara PS,
Sandoval R, Peres SB, Neves RX, Silverio R, Maximiano LF, Otoch JP
and Seelaender M: Adipose tissue-derived factors as potential
biomarkers in cachectic cancer patients. Cytokine. 61:532–539.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andò S, Barone I, Giordano C, Bonofiglio D
and Catalano S: The multifaceted mechanism of leptin signaling
within tumor microenvironment in driving breast cancer growth and
progression. Front Oncol. 4:3402014.PubMed/NCBI
|
|
7
|
Chang CC, Wu MJ, Yang JY, Camarillo IG and
Chang CJ: Leptin-STAT3-G9a signaling promotes obesity-mediated
breast cancer progression. Cancer Res. 75:2375–2386. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Visintin I, Feng Z, Longton G, Ward DC,
Alvero AB, Lai Y, Tenthorey J, Leiser A, Flores-Saaib R, Yu H, et
al: Diagnostic markers for early detection of ovarian cancer. Clin
Cancer Res. 14:1065–1072. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Serin IS, Tanriverdi F, Yilmaz MO, Ozcelik
B and Unluhizarci K: Serum insulin-like growth factor (IGF)-I, IGF
binding protein (IGFBP)-3, leptin concentrations and insulin
resistance in benign and malignant epithelial ovarian tumors in
postmenopausal women. Gynecol Endocrinol. 24:117–121. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
La Cava A and Matarese G: The weight of
leptin in immunity. Nat Rev Immunol. 4:371–379. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhou W, Guo S and Gonzalez-Perez RR:
Leptin pro-angiogenic signature in breast cancer is linked to IL-1
signalling. Br J Cancer. 104:128–137. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Vernooy JHJ, Ubags ND, Brusselle GG,
Tavernier J, Suratt BT, Joos GF, Wouters EF and Bracke KR: Leptin
as regulator of pulmonary immune responses: Involvement in
respiratory diseases. Pulm Pharmacol Ther. 26:464–472. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Geng Y, Wang J, Wang R, Wang K, Xu Y, Song
G, Wu C and Yin Y: Leptin and HER-2 are associated with gastric
cancer progression and prognosis of patients. Biomed Pharmacother.
66:419–424. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Harbuzariu A, Rampoldi A, Daley-Brown DS,
Candelaria P, Harmon TL, Lipsey CC, Beech DJ, Quarshie A, Ilies GO
and Gonzalez-Perez RR: Leptin-Notch signaling axis is involved in
pancreatic cancer progression. Oncotarget. 8:7740–7752. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Beales ILP, Garcia-Morales C, Ogunwobi OO
and Mutungi G: Adiponectin inhibits leptin-induced oncogenic
signalling in oesophageal cancer cells by activation of PTP1B. Mol
Cell Endocrinol. 382:150–158. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Jin JH, Kim HJ, Kim CY, Kim YH, Ju W and
Kim SC: Association of plasma adiponectin and leptin levels with
the development and progression of ovarian cancer. Obstet Gynecol
Sci. 59:279–285. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Housa D, Housová J, Vernerová Z and
Haluzík M: Adipocytokines and cancer. Physiol Res. 55:233–244.
2006.PubMed/NCBI
|
|
18
|
Trisolini C, Albrizio M, Roscino MT,
Pantaleo M, Rizzo A and Sciorsci RL: Leptin and queen ovary: New
insights about ovulation. Res Vet Sci. 94:707–710. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yu Y, Gaillard S, Phillip JM, Huang TC,
Pinto SM, Tessarollo NG, Zhang Z, Pandey A, Wirtz D, Ayhan A, et
al: Inhibition of spleen tyrosine kinase potentiates
paclitaxel-induced cytotoxicity in ovarian cancer cells by
stabilizing microtubules. Cancer Cell. 28:82–96. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Khan IU, Khan RU, Asif H, Alamgeer, Khalid
SH, Asghar S, Saleem M, Shah KU, Shah SU, Rizvi SAA and Shahzad Y:
Co-delivery strategies to overcome multidrug resistance in ovarian
cancer. Int J Pharm. 533:111–124. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Monk BJ, Herzog TJ and Tewari KS:
Evolution of chemosensitivity and resistance assays as predictors
of clinical outcomes in epithelial ovarian cancer patients. Curr
Pharm Des. 22:4717–4728. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Fletcher JI, Haber M, Henderson MJ and
Norris MD: ABC transporters in cancer: More than just drug efflux
pumps. Nat Rev Cancer. 10:147–156. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Iyer AK, Singh A, Ganta S and Amiji MM:
Role of integrated cancer nanomedicine in overcoming drug
resistance. Adv Drug Deliver Rev. 65:1784–1802. 2013. View Article : Google Scholar
|
|
24
|
Jabr-Milane LS, van Vlerken LE, Yadav S
and Amiji MM: Multi-functional nanocarriers to overcome tumor drug
resistance. Cancer Treat Rev. 34:592–602. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Mahmood K, Zia KM, Zuber M, Salman M and
Anjum MN: Recent developments in curcumin and curcumin based
polymeric materials for biomedical applications: A review. Int J
Biol Macromol. 81:877–890. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cuello MA, Kato S and Liberona F: The
impact on high-grade serous ovarian cancer of obesity and lipid
metabolism-related gene expression patterns: The underestimated
driving force affecting prognosis. J Cell Mol Med. 22:1805–1815.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Otero M, Lago R, Lago F, Reino JJ and
Gualillo O: Signalling pathway involved in nitric oxide synthase
type II activation in chondrocytes: Synergistic effect of leptin
with interleukin-1. Arthritis Res Ther. 7:R581–R591. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Vuolteenaho K, Koskinen A, Kukkonen M,
Nieminen R, Päivärinta U, Moilanen T and Moilanen E: Leptin
enhances synthesis of proinflammatory mediators in human
osteoarthritic cartilage-mediator role of NO in leptin-induced
PGE2, IL-6, and IL-8 production. Mediators Inflamm.
2009:3458382009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liang SQ, Marti TM, Dorn P, Froment L,
Hall SR, Berezowska S, Kocher G, Schmid RA and Peng RW: Blocking
the epithelial-to-mesenchymal transition pathway abrogates
resistance to anti-folate chemotherapy in lung cancer. Cell Death
Dis. 6:e18242015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Mitra A, Mishra L and Li S: EMT, CTCs and
CSCs in tumor relapse and drug-resistance. Oncotarget.
6:10697–10711. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Sánchez-Tilló E, Fanlo L, Siles L,
Montes-Moreno S, Moros A, Chiva-Blanch G, Estruch R, Martinez A,
Colomer D, Győrffy B, et al: The EMT activator ZEB1 promotes tumor
growth and determines differential response to chemotherapy in
mantle cell lymphoma. Cell Death Differ. 21:247–257. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim E, Lim S, Kim M, Yoo S and Kim Y:
Phyllodulcin, a natural sweetener, regulates obesity-related
metabolic changes and fat browning-related genes of subcutaneous
white adipose tissue in high-fat diet-induced obese mice.
Nutrients. 9(pii): E10492017. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Konopka B, Szafron LM, Kwiatkowska E,
Podgorska A, Zolocinska A, Pienkowska-Grela B, Dansonka-Mieszkowska
A, Balcerak A, Lukasik M, Stachurska A, et al: The significance of
c.690G>T polymorphism (rs34529039) and expression of the CEBPA
gene in ovarian cancer outcome. Oncotarget. 7:67412–67424. 2016.
View Article : Google Scholar : PubMed/NCBI
|
